Connecticut Capital Management Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Sell
744
-103
-12% -$35.3K 0.22% 99
2026
Q1
$298K Buy
847
+8
+1% +$2.85K 0.28% 77
2025
Q4
$275K Buy
+839
New +$266K 0.26% 71

Other funds holding AMGN

Connecticut Capital Management Group's AMGN Position: Q2 2026 in Review

Connecticut Capital Management Group reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $35.3K and leaving 744 shares worth $269K. The position accounts for 0.22% of the portfolio, ranked #99.

Connecticut Capital Management Group first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $298K in Q1 2026. 3,134 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Connecticut Capital Management Group held 744 shares of Amgen worth $269K as of Q2 2026.
  • Connecticut Capital Management Group sold 103 Amgen shares in Q2 2026, an estimated $35.3K.
  • Amgen made up 0.22% of Connecticut Capital Management Group's portfolio in Q2 2026, its #99 holding.
  • Connecticut Capital Management Group first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Connecticut Capital Management Group's Amgen position peaked at $298K in Q1 2026.
  • 3,134 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Connecticut Capital Management Group's 13F filing for Q2 2026, filed 20 Jul 2026.